These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 7110143)

  • 61. Non-specific MIF-like activity induced by the synthetic immunoadjuvant: N-acetyl muramyl-L-alanyl-D-isoglutamine (MDP).
    Adam A; Souvannavong V; Lederer E
    Biochem Biophys Res Commun; 1978 Nov; 85(2):684-90. PubMed ID: 367370
    [No Abstract]   [Full Text] [Related]  

  • 62. Dissociation between muramyl dipeptide-induced fever and changes in plasma metal levels.
    Riveau G; Parant M; Damais C; Parant F; Chedid L
    Am J Physiol; 1986 Apr; 250(4 Pt 1):C572-7. PubMed ID: 3963170
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Genetic influences on the adjuvanticity of muramyl dipeptide in vivo.
    Staruch MJ; Wood DD
    J Immunol; 1982 Jan; 128(1):155-60. PubMed ID: 6976368
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Macrophage activation by bacterial cell walls and related synthetic compounds.
    Takada H; Tsujimoto M; Kato K; Kotani S; Kusumoto S; Inage M; Shiba T; Yano I; Kawata S; Yokogawa K
    Infect Immun; 1979 Jul; 25(1):48-53. PubMed ID: 478648
    [TBL] [Abstract][Full Text] [Related]  

  • 65. In vivo and in vitro stimulation of nonspecific immunity by the beta-D-p-aminophenyl glycoside of N-acetylmuramyl-L-alanyl-D-isoglutamine and an oligomer prepared by cross-linking with glutaraldehyde.
    Parant M; Damais C; Audibert F; Parant F; Chedid L; Sache E; Lefrancier P; Choay J; Lederer E
    J Infect Dis; 1978 Sep; 138(3):378-86. PubMed ID: 100563
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Synthesis of some new analogs of the immunoadjuvant glycopeptide MDP (N-acetyl-muramyl-L-alanyl-D-isoglutamine).
    Lefrancier P; Derrien M; Lederman I; Nief F; Choay J; Lederer E
    Int J Pept Protein Res; 1978 Apr; 11(4):289-96. PubMed ID: 669885
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Muramyl-peptide/gastrin conjugates as potential immunogens.
    Moroder L; Dufresne M; Göhring W; Wünsch E; Leidinger E; Gemeiner M
    Biol Chem Hoppe Seyler; 1989 Nov; 370(11):1209-14. PubMed ID: 2610937
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Past, present and future of the synthetic immunoadjuvant MDP and its analogs.
    Chedid L; Lederer E
    Biochem Pharmacol; 1978; 27(18):2183-6. PubMed ID: 365182
    [No Abstract]   [Full Text] [Related]  

  • 69. The pyrogenicity of the synthetic adjuvant muramyl dipeptide and two structural analogues.
    Dinarello CA; Elin RJ; Chedid L; Wolff SM
    J Infect Dis; 1978 Dec; 138(6):760-7. PubMed ID: 368262
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Muramyl peptides. Variation of somnogenic activity with structure.
    Krueger JM; Walter J; Karnovsky ML; Chedid L; Choay JP; Lefrancier P; Lederer E
    J Exp Med; 1984 Jan; 159(1):68-76. PubMed ID: 6693833
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Stimulation of the in vivo dinitrophenyl antibody response to the DNP conjugate of L-glutamic acid60-L-alanine30-L-Tyrosine10 (GAT) polymer by a synthetic adjuvant, muramyl dipeptide (MDP): target cells for adjuvant activity and isotypic pattern of MDP-stimulated response.
    Lowy I; Theze J; Chedid L
    J Immunol; 1980 Jan; 124(1):100-4. PubMed ID: 6965289
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Influence of indomethacin on various immunopharmacological effects of muramyl dipeptide (MDP).
    Parant M; Riveau G; Chedid L
    Agents Actions Suppl; 1980; 7():33-40. PubMed ID: 6941684
    [TBL] [Abstract][Full Text] [Related]  

  • 73. New developments in the field of synthetic muramyl peptides, especially as adjuvants for synthetic vaccines.
    Lederer E
    Drugs Exp Clin Res; 1986; 12(6-7):429-40. PubMed ID: 3527628
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Decrease in pyrogenicity of muramyl dipeptide after coupling with luteinizing hormone-releasing hormone.
    Riveau G; Hosmalin A; Carelli C; Lefrancier P; Chedid L
    J Leukoc Biol; 1988 Nov; 44(5):448-54. PubMed ID: 3053952
    [TBL] [Abstract][Full Text] [Related]  

  • 75. The macrophage, target cell of the synthetic adjuvant muramyl dipeptide.
    Fevrier M; Birrien JL; Leclerc C; Chedid L; Liacopoulos P
    Eur J Immunol; 1978 Aug; 8(8):558-62. PubMed ID: 359336
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Enhancement of endotoxic shock by N-acetylmuramyl-L-alanyl-(L-seryl)-D-isoglutamine (muramyl dipeptide).
    Ribi EE; Cantrell JL; Von Eschen KB; Schwartzman SM
    Cancer Res; 1979 Nov; 39(11):4756-9. PubMed ID: 115579
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Syntheses of polymeric vesicles containing partial structures of N-acetyl-muramyl-dipeptide (MDP).
    Hönig H; Zenk R
    Chem Phys Lipids; 1990 Mar; 53(4):347-56. PubMed ID: 2340605
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Immunostimulation with muramyl dipeptide and its desmethyl analogue: Studies of non-specific resistance to pulmonary blastomycosis in inbred mouse strains.
    Morozumi PA; Brummer E; Stevens DA
    Mycopathologia; 1983 Jan; 81(1):35-9. PubMed ID: 6835353
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Muramyl dipeptide-induced sleep and fever: effects of ambient temperature and time of injections.
    Shoham S; Krueger JM
    Am J Physiol; 1988 Jul; 255(1 Pt 2):R157-65. PubMed ID: 3394839
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Induction of tumoricidal macrophages and production of cytokines by synthetic muramyl dipeptide analogues.
    Saiki I; Saito S; Fujita C; Ishida H; Iida J; Murata J; Hasegawa A; Azuma I
    Vaccine; 1988 Jun; 6(3):238-44. PubMed ID: 2844032
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.